Overview

Azacitidine Compared to Conventional Chemotherapy as Consolidation of Elderly Patients With AML

Status:
Terminated
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Azacitidine consolidation is superior to standard DA consolidation treatment of acute myeloid leukemia in first complete remission in elderly patients.
Phase:
Phase 2
Details
Lead Sponsor:
Karolinska University Hospital
Collaborator:
Celgene Corporation
Treatments:
Azacitidine
Cytarabine
Daunorubicin